Literature DB >> 1319458

A monkey model for Epstein Barr virus-associated lymphomagenesis in human acquired immunodeficiency syndrome.

H Feichtinger1, S L Li, E Kaaya, P Putkonen, K Grünewald, K Weyrer, D Böttiger, I Ernberg, A Linde, G Biberfeld.   

Abstract

High-grade malignant nonHodgkin's lymphomas--five lymphoblastic, three pleomorphic, and two immunoblastic--developed in 10/25 cynomolgus monkeys (Macaca fascicularis) followed for up to 746 d after infection with simian immunodeficiency virus, strain SIVsm. These lymphomas were shown to be associated with an Epstein-Barr (EB)-like cynomolgus B-lymphotropic herpesvirus (CBLV) by electron microscopy, by Southern blot hybridization with probes against human EBV, and by the expression of antigens corresponding to EBV-associated nuclear antigens (EBNAs) involved in human B cells transformation. Southern blot demonstration of immunoglobulin gene rearrangements and homogeneous EBV episomes indicated that all the lymphomas were CBLV-associated monoclonal B cell proliferations. Our findings suggest that these tumors correspond to the EBV-associated malignant lymphomas in acquired immunodeficiency syndrome with respect to clinical, morphological, phenotypic, and genotypic characteristics. The particular susceptibility of SIVsm immunodeficient cynomolgus monkeys for CBLV-associated lymphomagenesis appears therefore a useful model for EBV-associated lymphomas in humans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319458      PMCID: PMC2119285          DOI: 10.1084/jem.176.1.281

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Acquired immunodeficiency syndrome-associated lymphomas: clinical, pathologic, immunologic, and viral characteristics of 111 cases.

Authors:  H L Ioachim; B Dorsett; W Cronin; M Maya; S Wahl
Journal:  Hum Pathol       Date:  1991-07       Impact factor: 3.466

2.  Nuclear DNA-binding proteins determined by the Epstein-Barr virus-related simian lymphotropic herpesviruses H. gorilla, H. pan, H. pongo and H. papio.

Authors:  J Dillner; H Rabin; N Letvin; W Henle; G Henle; G Klein
Journal:  J Gen Virol       Date:  1987-06       Impact factor: 3.891

3.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

4.  DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

Authors:  R Baer; A T Bankier; M D Biggin; P L Deininger; P J Farrell; T J Gibson; G Hatfull; G S Hudson; S C Satchwell; C Séguin
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

5.  Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986).

Authors:  D M Knowles; G A Chamulak; M Subar; J S Burke; M Dugan; J Wernz; C Slywotzky; G Pelicci; R Dalla-Favera; B Raphael
Journal:  Ann Intern Med       Date:  1988-05       Impact factor: 25.391

6.  Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections.

Authors:  A Linde; J Andersson; G Lundgren; B Wahren
Journal:  J Med Virol       Date:  1987-02       Impact factor: 2.327

7.  Transmissible lymphoma and simian acquired immunodeficiency syndrome in rhesus monkeys.

Authors:  G B Baskin; L N Martin; S R Rangan; B J Gormus; M Murphey-Corb; R H Wolf; K F Soike
Journal:  J Natl Cancer Inst       Date:  1986-07       Impact factor: 13.506

8.  Malignant lymphomas in cynomolgus monkeys infected with simian immunodeficiency virus.

Authors:  H Feichtinger; P Putkonen; C Parravicini; S L Li; E E Kaaya; D Böttiger; G Biberfeld; P Biberfeld
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

9.  Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene.

Authors:  M D Erisman; P G Rothberg; R E Diehl; C C Morse; J M Spandorfer; S M Astrin
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

10.  Clinical features and predictive markers of disease progression in cynomolgus monkeys experimentally infected with simian immunodeficiency virus.

Authors:  P Putkonen; E E Kaaya; D Böttiger; S L Li; C Nilsson; P Biberfeld; G Biberfeld
Journal:  AIDS       Date:  1992-03       Impact factor: 4.177

View more
  17 in total

1.  Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells.

Authors:  Donna Hochberg; Tatyana Souza; Michelle Catalina; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

2.  Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses.

Authors:  R Peng; A V Gordadze; E M Fuentes Pananá; F Wang; J Zong; G S Hayward; J Tan; P D Ling
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits.

Authors:  K Hayashi; N Ohara; N Teramoto; S Onoda; H L Chen; T Oka; E Kondo; T Yoshino; K Takahashi; J Yates; T Akagi
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

4.  Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections.

Authors:  P Rao; H Jiang; F Wang
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

Review 5.  Simian herpesviruses and their risk to humans.

Authors:  Ryan D Estep; Ilhem Messaoudi; Scott W Wong
Journal:  Vaccine       Date:  2010-05-26       Impact factor: 3.641

6.  Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus.

Authors:  A Moghaddam; J Koch; B Annis; F Wang
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Malignant lymphomas induced by an Epstein-Barr virus-related herpesvirus from Macaca arctoides--a rabbit model.

Authors:  P Wutzler; A Meerbach; I Färber; H Wolf; K Scheibner
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  Therapeutic vaccination against the rhesus lymphocryptovirus EBNA-1 homologue, rhEBNA-1, elicits T cell responses to novel epitopes in rhesus macaques.

Authors:  Eduardo L V Silveira; Mark H Fogg; Rachel M Leskowitz; Hildegund C Ertl; Roger W Wiseman; David H O'Connor; Paul Lieberman; Fred Wang; Francois Villinger
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

9.  Post-transplant lymphoproliferative disorder associated with immunosuppressive therapy for renal transplantation in rhesus macaques (Macaca mulatta).

Authors:  Eugenia K Page; Cynthia L Courtney; Prachi Sharma; Jennifer Cheeseman; Joe B Jenkins; Elizabeth Strobert; Stuart J Knechtle
Journal:  Exp Toxicol Pathol       Date:  2013-04-08

10.  Nonhuman primate infections after organ transplantation.

Authors:  Silke V Haustein; Amanda J Kolterman; Jeffrey J Sundblad; John H Fechner; Stuart J Knechtle
Journal:  ILAR J       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.